Dracocephalum palmatum Stephan 잎 헥산 분획 추출물의 인간 유래 전립선 암세포 사멸에 대한 작용 = Effects of hexane fraction of Dracocephalum palmatum Stephan leaf on human-derived prostate cancer cell death

다국어 초록 (Multilingual Abstract)

Objectives : Dracocephalum palmatum Stephan (Lamiaceae) is a medicinal plant used by the East-Russian nomads but there were few studies on this plant. This study was to evaluate anti-cancer effects of D. palmatum Stephan leaf hexane fraction on human derived prostate cancer cell death.
Methods : The dried leaves of D. palmatum were dissolved in methanol, and hexane fraction (DpLH) was again obtained from lyophilized methanol extract (DpLM). DpLH was investigated by measuring by MTT assay and annexin V/PI staining to evaluate its effects on the cell viability and apoptosis of PC-3 cells. The ROS generations were detected by DCF-DA dye. The protein expressions were confirmed by p-AKT, Bcl-2, Bax, procaspase-3 activities.
Results : After treatment of DpLH to PC-3 cells, the cell proliferation was significantly inhibited, and in addition, DpLH treatment also accelerated apoptosis of PC-3 cells. When DpLH was treated to the PC-3 cells, its ROS production significantly decreased. The proportion of all proteins (p-AKT/actin, Bcl-2/Bax and procaspase-3/actin ratios) showed decreasing tendency of expression compared with the control group.
Conclusions : As shown in the above results, the extract from D. palmatum inhibits ROS production and promotes cell death, which is considered to be a relatively safe induction of cell death when administered to a living body. In conclusion, these results suggested that DpLH may have anti-cancer effect in human prostate cancer cell.

참고문헌 (Reference)

1 Jahaniani F, "Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent" 66 (66): 1581-1592, 2005

2 Hamzehzadeh L, "The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway" 2018

3 Kim R, "The role of apoptosis in cancer cell survival and therapeutic outcome" 5 (5): 1429-1442, 2006

4 Himmelfarb J, "The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia" 62 (62): 1524-1538, 2002

5 Lee KC, "Seed germination characteristics of Dracocephalum foetidum and Dracocephalum argunense" 164-165, 2009

6 Simon HU, "Role of reactive oxygen species (ROS) in apoptosis induction" 5 (5): 415-418, 2000

7 Ola MS, "Role of Bcl-2 family proteins and caspases in the regulation of apoptosis" 351 (351): 41-58, 2011

8 Cairns RA, "Regulation of cancer cell metabolism" 11 (11): 85-95, 2011

9 Nishikawa M, "Reactive oxygen species in tumor metastasis" 266 (266): 53-59, 2008

10 Ray PD, "Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling" 24 (24): 981-990, 2012

11 Reiter RE, "Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer" 95 (95): 1735-1740, 1998

12 Maitland NJ, "Prostate cancer stem cells: A new target for therapy" 26 (26): 2862-2870, 2008

13 Pantuck AJ, "PhaseIIstudyofpomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer" 12 (12): 4018-4026, 2006

14 Altomare DA, "Perturbations of the AKT signaling pathway in human cancer" 24 (24): 7455-7464, 2005

15 Esmaeili MA, "Oxidative stress protective effect of Dracocephalum multicaule essential oil against human cancer cell line" 28 (28): 848-852, 2014

16 Uttara B, "Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options" 7 (7): 65-74, 2009

17 Zhong H, "Overexpression of hypoxia-inducible factor 1${\alpha}$ in common human cancers and their metastases" 59 (59): 5830-5835, 1999

18 Talari M, "Dracocephalum: novel anticancer plant acting on liver cancer cell mitochondria" 2014

19 Dearnaley DP, "Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial" 353 (353): 267-272, 1999

20 Danial NN, "Cell death: critical control points" 116 (116): 205-219, 2004

21 Hotchkiss RS, "Cell death" 361 (361): 1570-1583, 2009

22 Siegel RL, "Cancer Statistics, 2017" 67 (67): 7-30, 2017

23 Elmore S, "Apoptosis: a review of programmed cell death" 35 (35): 495-516, 2007

24 Gerl R, "Apoptosis in the development and treatment of cancer" 26 (26): 263-270, 2005

25 Wong RS, "Apoptosis in cancer: from pathogenesis to treatment" 30 : 87-, 2011

26 Pistritto G, "Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies" 8 (8): 603-619, 2016

27 Kakasy A, "Analysis of non-volatile constituents in Dracocephalum species by HPLC and GC-MS" 63 (63): S17-S22, 2006

28 Kontush A, "Amyloid-${\beta}$: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease" 31 (31): 1120-1131, 2001

29 Qiu M, "A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells" 2015